|
US4838925A
(en)
|
1986-04-25 |
1989-06-13 |
E. I. Du Pont De Nemours And Company |
Heterocyclic acyl sulfonamides
|
|
JP3763997B2
(ja)
|
1999-05-13 |
2006-04-05 |
富士写真フイルム株式会社 |
感熱記録材料
|
|
JP4331823B2
(ja)
|
1999-05-21 |
2009-09-16 |
富士フイルム株式会社 |
ピロロ［１，２−ａ］−１，３，５−トリアジン−４−オン系化合物
|
|
MXPA02006660A
(es)
|
2000-01-07 |
2002-12-13 |
Transform Pharmaceuticals Inc |
Formacion, identificacion y analisis de diversas formas solidas de alto rendimiento.
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
JP4070966B2
(ja)
|
2001-06-28 |
2008-04-02 |
株式会社カネボウ化粧品 |
新規ガラクトシルセラミド類縁体及び用途
|
|
ATE307812T1
(de)
|
2001-10-22 |
2005-11-15 |
Pfizer |
Imidazopyridinverbindungen als 5-ht4- rezeptormodulatoren
|
|
KR20040087335A
(ko)
|
2002-03-01 |
2004-10-13 |
야마노우치세이야쿠 가부시키가이샤 |
질소 함유 복소환 화합물
|
|
DOP2003000703A
(es)
|
2002-09-20 |
2004-03-31 |
Pfizer |
Compuestos de imidazopiradina como agonistas del receptor 5-ht4
|
|
JP2006502180A
(ja)
|
2002-09-20 |
2006-01-19 |
ファイザー株式会社 |
５−ｈｔ４レセプターモジュレーターとしてのｎ−置換されたピペリジニル−イミダゾピリジン化合物
|
|
US7550470B2
(en)
|
2002-12-11 |
2009-06-23 |
Merck & Co. Inc. |
Substituted pyrazolo[1,5-A]pyrimidines as tyrosine kinase inhibitors
|
|
JP2004277337A
(ja)
|
2003-03-14 |
2004-10-07 |
Sumitomo Pharmaceut Co Ltd |
ピラゾロ［１，５−ａ］ピリミジン誘導体
|
|
WO2004094418A1
(en)
|
2003-04-21 |
2004-11-04 |
Pfizer Inc. |
Imidazopyridine compounds having 5-ht4 receptor agonistic activity and 5-ht3 receptor antagonistic activity
|
|
EP1682504B1
(en)
|
2003-11-12 |
2012-12-26 |
Amicus Therapeutics Inc. |
Hydroxy piperidine derivatives to treat gaucher disease
|
|
GB0329214D0
(en)
*
|
2003-12-17 |
2004-01-21 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0400812D0
(en)
|
2004-01-14 |
2004-02-18 |
Celltech R&D Ltd |
Novel compounds
|
|
JPWO2005077953A1
(ja)
|
2004-02-18 |
2007-10-18 |
萬有製薬株式会社 |
含窒素縮合ヘテロ芳香環誘導体
|
|
ATE396725T1
(de)
|
2004-05-14 |
2008-06-15 |
Cleveland Clinic Foundation |
Kleinmolekülige hemmer für mrp1 und andere multiarzneimitteltransporter
|
|
RU2378277C2
(ru)
|
2004-06-21 |
2010-01-10 |
Ф. Хоффманн-Ля Рош Аг |
Производные пиразолпиримидина
|
|
BRPI0514015A
(pt)
|
2004-08-02 |
2008-05-27 |
Sanol Arznei Schwarz Gmbh |
carboxamidas da indolizina e seus derivados aza e diaza
|
|
DE102004049363A1
(de)
|
2004-10-08 |
2006-04-13 |
Henkel Kgaa |
Mittel zum Färben von keratinhaltigen Fasern
|
|
WO2006078676A2
(en)
|
2005-01-19 |
2006-07-27 |
Merck & Co., Inc. |
Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
|
|
ATE512966T1
(de)
|
2005-02-11 |
2011-07-15 |
Hoffmann La Roche |
Pyrazolo-pyrimidin-derivate als mglur2- antagonisten
|
|
DE102005007534A1
(de)
|
2005-02-17 |
2006-08-31 |
Bayer Cropscience Ag |
Pyrazolopyrimidine
|
|
WO2006115168A1
(ja)
|
2005-04-21 |
2006-11-02 |
Dainippon Sumitomo Pharma Co., Ltd. |
Ｎ－置換フェニルアセトアミド誘導体およびそれを含有する医薬組成物
|
|
JP5079500B2
(ja)
|
2005-04-28 |
2012-11-21 |
協和発酵キリン株式会社 |
２−アミノキナゾリン誘導体
|
|
US7632837B2
(en)
|
2005-06-17 |
2009-12-15 |
Bristol-Myers Squibb Company |
Bicyclic heterocycles as cannabinoid-1 receptor modulators
|
|
US7723336B2
(en)
|
2005-09-22 |
2010-05-25 |
Bristol-Myers Squibb Company |
Fused heterocyclic compounds useful as kinase modulators
|
|
EP1931675B1
(en)
|
2005-10-06 |
2015-01-14 |
Merck Sharp & Dohme Corp. |
Pyrazolo(1, 5a) pyrimidines as protein kinase inhibitors
|
|
WO2007048065A2
(en)
|
2005-10-21 |
2007-04-26 |
Exelixis, Inc. |
Pyrimidinones as casein kinase ii (ck2) modulators
|
|
KR20080074161A
(ko)
|
2005-12-08 |
2008-08-12 |
노파르티스 아게 |
ＥＰＨＢ 및 ＶＥＧＦＲ２ 키나아제 억제제로서의피라졸로[１,５-ａ]피리딘-３-카르복실산
|
|
TW200800997A
(en)
*
|
2006-03-22 |
2008-01-01 |
Astrazeneca Ab |
Chemical compounds
|
|
CA2656643C
(en)
|
2006-06-23 |
2015-08-25 |
Amicus Therapeutics, Inc. |
Method for the treatment of neurological disorders by enhancing the activity of .beta.-glucocerebrosidase
|
|
AR061793A1
(es)
|
2006-07-05 |
2008-09-24 |
Mitsubishi Tanabe Pharma Corp |
Compuesto de pirazolo[1,5-a] pirimidina y composicion farmaceutica
|
|
WO2008019363A2
(en)
|
2006-08-07 |
2008-02-14 |
Albany Molecular Research, Inc. |
2-alkylbenzoxazole carboxamides as 5ht3 modulators
|
|
WO2008063671A2
(en)
|
2006-11-20 |
2008-05-29 |
Alantos Pharmaceuticals Holding, Inc. |
Heterobicyclic metalloprotease inhibitors
|
|
US20080221092A1
(en)
|
2006-11-20 |
2008-09-11 |
Harald Bluhm |
Heterobicyclic metalloprotease inhibitors
|
|
WO2008116898A1
(en)
|
2007-03-28 |
2008-10-02 |
Biovitrum Ab (Publ) |
Pyrazolo [1,5-a]pyrimidines as inhibitors of stearoyl-coa desaturase
|
|
AR067326A1
(es)
|
2007-05-11 |
2009-10-07 |
Novartis Ag |
Imidazopiridinas y pirrolo -pirimidinas sustituidas como inhibidores de cinasa de lipido
|
|
KR20100035635A
(ko)
|
2007-06-21 |
2010-04-05 |
아이알엠 엘엘씨 |
단백질 키나제 억제제 및 그의 사용 방법
|
|
JP5479105B2
(ja)
|
2007-11-05 |
2014-04-23 |
国立大学法人佐賀大学 |
新規ユビキリン結合性小分子
|
|
EP2217601A1
(en)
|
2007-11-08 |
2010-08-18 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyridazines for use as protein kinase inhibitors
|
|
JP2011504931A
(ja)
|
2007-11-28 |
2011-02-17 |
シェーリング コーポレイション |
プロテインキナーゼ阻害剤としての２−フルオロピラゾロ［１，５−ａ］ピリミジン
|
|
CN101981033B
(zh)
|
2008-02-06 |
2015-02-04 |
百时美施贵宝公司 |
用作激酶抑制剂的取代的咪唑并哒嗪化合物
|
|
JPWO2009119088A1
(ja)
|
2008-03-25 |
2011-07-21 |
武田薬品工業株式会社 |
複素環化合物
|
|
MX2010012010A
(es)
|
2008-05-01 |
2010-11-30 |
Sirtris Pharmaceuticals Inc |
Quinolinas y analogos relacionados como moduladores de sirtuin.
|
|
CA2736335C
(en)
|
2008-10-14 |
2017-05-09 |
Astrazeneca Ab |
Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
|
|
WO2010051549A1
(en)
*
|
2008-10-31 |
2010-05-06 |
Genentech, Inc. |
Pyrazolopyrimidine jak inhibitor compounds and methods
|
|
WO2010086040A1
(en)
|
2009-01-29 |
2010-08-05 |
Biomarin Iga, Ltd. |
Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
|
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
|
GEP201706639B
(en)
|
2009-08-17 |
2017-03-27 |
Intellikine Llc |
Heterocyclic compounds and uses thereof
|
|
EP2593457B1
(en)
*
|
2010-07-13 |
2017-08-23 |
F. Hoffmann-La Roche AG |
Pyrazolo[1,5a]pyrimidine and thieno[3,2b]pyrimidine derivatives as irak4 modulators
|
|
WO2012034095A1
(en)
|
2010-09-09 |
2012-03-15 |
Irm Llc |
Compounds and compositions as trk inhibitors
|
|
TW201217312A
(en)
|
2010-09-22 |
2012-05-01 |
Gruenenthal Gmbh |
Substituted benzamide compounds
|
|
WO2012075393A2
(en)
|
2010-12-02 |
2012-06-07 |
President And Fellows Of Harvard College |
Activators of proteasomal degradation and uses thereof
|
|
SI3366688T1
(sl)
|
2010-12-08 |
2022-07-29 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Substituirani pirazolopirimidini kot aktivatorji glukocerebrozidaze
|
|
JP5808826B2
(ja)
|
2011-02-23 |
2015-11-10 |
インテリカイン， エルエルシー |
複素環化合物およびその使用
|
|
WO2012129258A1
(en)
*
|
2011-03-22 |
2012-09-27 |
Merck Sharp & Dohme Corp. |
Amidopyrazole inhibitors of interleukin receptor-associated kinases
|
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
CA2844794C
(en)
|
2011-08-18 |
2018-02-20 |
Nippon Shinyaku Co., Ltd. |
Heterocyclic derivatives with mpges-1 inhibitory activity
|
|
JP6054967B2
(ja)
|
2011-09-02 |
2016-12-27 |
バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ |
置換アネレート化ピリミジンおよびその使用
|
|
WO2013059119A1
(en)
|
2011-10-17 |
2013-04-25 |
The Regents Of The University Of Michigan |
Glucosylceramide synthase inhibitors and therapeutic methods using the same
|
|
RU2014120166A
(ru)
|
2011-10-20 |
2015-11-27 |
ГЛЭКСОСМИТКЛАЙН ЭлЭлСи |
Замещенные бициклические аза-гетероциклы и их аналоги в качестве модуляторов сиртуина
|
|
EP2794592A1
(en)
|
2011-12-23 |
2014-10-29 |
Novartis AG |
Compounds for inhibiting the interaction of bcl2 with binding partners
|
|
WO2013134079A1
(en)
*
|
2012-03-05 |
2013-09-12 |
Amgen Inc. |
Oxazolidinone compounds and derivatives thereof
|
|
MX347917B
(es)
|
2012-03-09 |
2017-05-17 |
Lexicon Pharmaceuticals Inc |
Compuestos a base de imidazo[1,2-b]piridazina, composiciones que los comprenden, y metodos para su uso.
|
|
US20140080834A1
(en)
|
2012-03-09 |
2014-03-20 |
Thomas Herbert Lanthorn |
Inhibition of adaptor associated kinase 1 for the treatment of pain
|
|
JP2015512913A
(ja)
|
2012-03-28 |
2015-04-30 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
グルコセレブロシダーゼ活性剤として有用なサリチル酸誘導体
|
|
WO2013178591A1
(en)
|
2012-05-31 |
2013-12-05 |
F. Hoffmann-La Roche Ag |
Aminoquinazoline and pyridopyrimidine derivatives
|
|
WO2013191112A1
(ja)
|
2012-06-22 |
2013-12-27 |
住友化学株式会社 |
縮合複素環化合物
|
|
WO2014025651A1
(en)
*
|
2012-08-06 |
2014-02-13 |
Amgen Inc. |
Chroman derivatives as trpm8 inhibitors
|
|
CN104780764A
(zh)
|
2012-09-05 |
2015-07-15 |
拜尔农作物科学股份公司 |
取代的2-酰氨基苯并咪唑、2-酰氨基苯并噁唑和2-酰氨基苯并噻唑或其盐作为活性物质对抗非生物植物胁迫的用途
|
|
AU2013344716B2
(en)
|
2012-11-16 |
2018-03-01 |
University Health Network |
Pyrazolopyrimidine compounds
|
|
US9938258B2
(en)
|
2012-11-29 |
2018-04-10 |
Karyopharm Therapeutics Inc. |
Substituted 2,3-dihydrobenzofuranyl compounds and uses thereof
|
|
TWI618706B
(zh)
*
|
2012-12-07 |
2018-03-21 |
維泰克斯製藥公司 |
用作ａｔｒ激酶抑制劑之化合物
|
|
KR20140086002A
(ko)
|
2012-12-28 |
2014-07-08 |
한미약품 주식회사 |
Fms 키나아제 저해 활성을 갖는 피리다진 접합고리 유도체
|
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
|
WO2014144455A1
(en)
|
2013-03-15 |
2014-09-18 |
Epizyme, Inc. |
1 -phenoxy-3-(alkylamino)-propan-2-ol derivatives as carm1 inhibitors and uses thereof
|
|
WO2015012328A1
(ja)
|
2013-07-24 |
2015-01-29 |
武田薬品工業株式会社 |
複素環化合物
|
|
WO2015026574A1
(en)
|
2013-08-20 |
2015-02-26 |
Bristol-Myers Squibb Company |
Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia
|
|
TW201605866A
(zh)
|
2013-08-23 |
2016-02-16 |
英塞特公司 |
可用作ｐｉｍ激酶抑制劑之呋喃并－及噻吩并－吡啶甲醯胺化合物
|
|
AR097543A1
(es)
|
2013-09-06 |
2016-03-23 |
Lexicon Pharmaceuticals Inc |
COMPUESTOS BASADOS EN IMIDAZO[1,2-b]PIRIDAZINA, COMPOSICIONES QUE LOS COMPRENDEN Y SUS MÉTODOS DE USO
|
|
TW201542550A
(zh)
|
2013-09-06 |
2015-11-16 |
Lexicon Pharmaceuticals Inc |
吡唑并［１，５－ａ］嘧啶基化合物、包含彼之組合物以及使用彼之方法
|
|
WO2015073267A1
(en)
|
2013-11-15 |
2015-05-21 |
Calitor Sciences, Llc |
Substituted heteroaryl compounds and methods of use
|
|
ES2895490T3
(es)
|
2014-03-27 |
2022-02-21 |
Acad Medisch Ct |
Iminoazúcares N-(5-(bifen-4-ilmetiloxi)pentil)-sustituidos como inhibidores de glucosilceramida sintasa
|
|
US9695180B2
(en)
|
2014-07-10 |
2017-07-04 |
Incyte Corporation |
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
|
|
EP3215509B1
(en)
|
2014-11-06 |
2020-02-26 |
Lysosomal Therapeutics Inc. |
Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
|
|
EP4406616A3
(en)
|
2014-11-06 |
2024-11-06 |
Bial-R&D Investments, S.A. |
Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders
|
|
WO2016073889A1
(en)
|
2014-11-06 |
2016-05-12 |
Lysosomal Therapeutics Inc. |
Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
|
|
JP2018525345A
(ja)
|
2015-07-01 |
2018-09-06 |
ノースウェスタン ユニバーシティ |
置換キナゾリン化合物及びグルコセレブロシダーゼ活性の調節のためのその使用
|
|
EP3317282B1
(en)
|
2015-07-01 |
2020-12-09 |
Northwestern University |
Substituted 4-methyl-pyrrolo[1.2-a]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activity
|
|
US20190092789A1
(en)
|
2015-09-04 |
2019-03-28 |
Lysosomal Therapeutics Inc. |
Heterobicyclic pyrimidinone compounds and their use in the treatment of medical disorders
|
|
PL3371190T3
(pl)
|
2015-11-06 |
2022-11-07 |
Incyte Corporation |
Związki heterocykliczne jako inhibitory pi3k-gamma
|
|
WO2017087590A1
(en)
|
2015-11-18 |
2017-05-26 |
Bristol-Myers Squibb Company |
Imidazopyridazine compounds useful as modulators of il-12, il-23 and/or ifn alpha responses
|
|
CN108473501B
(zh)
|
2016-02-18 |
2021-07-16 |
豪夫迈·罗氏有限公司 |
治疗化合物、其组合物及使用方法
|
|
JP7046827B2
(ja)
|
2016-04-06 |
2022-04-04 |
リソソーマル・セラピューティクス・インコーポレイテッド |
イミダゾ［１，５－ａ］ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用
|
|
KR20230104752A
(ko)
|
2016-04-06 |
2023-07-10 |
비알 - 알&디 인베스트먼츠, 에스.에이. |
피라졸로[1,5-a]피리미디닐 카르복스아미드 화합물및 의학적 장애의 치료에서의 그의 용도
|
|
JP7034935B2
(ja)
|
2016-04-06 |
2022-03-14 |
リソソーマル・セラピューティクス・インコーポレイテッド |
ピロロ［１，２－ａ］ピリミジニルカルボキサミド化合物および医学的障害の処置におけるその使用
|
|
WO2017192841A1
(en)
|
2016-05-04 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds
|
|
EP3452455A4
(en)
|
2016-05-05 |
2019-11-13 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED IMDAZO [1,2-] PYRIDINES, SUBSTITUTED IMIDAZO [1,2-] PYRAZINES, RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF ILLNESSES
|
|
WO2017192930A1
(en)
|
2016-05-05 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED IMIDAZO[1,2-b]PYRIDAZINES, SUBSTITUTED IMIDAZO[1,5-b]PYRIDAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
WO2017192929A1
(en)
|
2016-05-05 |
2017-11-09 |
Lysosomal Therapeutics Inc. |
SUBSTITUTED PYRROLO[1,2-α]TRIAZINES AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
|
|
EP3728265A1
(en)
|
2017-12-21 |
2020-10-28 |
BIAL - BioTech Investments, Inc. |
Crystalline substituted cyclohexyl pyrazolo[1,5-a]pyrimidinyl carboxamide compound and therapeutic uses thereof
|
